Literature DB >> 9100671

Clinical and neuropathological study of six patients with spastic paraparesis associated with HTLV-I: an axomyelinic degeneration of the central nervous system.

L M Cartier1, J G Cea, C Vergara, F Araya, P Born.   

Abstract

Between 1990 to 1994, 6 TSP/HAM patients, 3 women and 3 men with an average age of 57.1 years (39 to 76 years old), who died in the Salvador Hospital were submitted to postmortem examination. The mean time of paraparesis was 7 years (3 to 17 years), and 2 patients had pseudobulbar signs. Three cases had macroscopic atrophy of the spinal cord. Histologically, all cases had lesions in the pyramidal tracts and 4 cases showed somatotopic lesions of the Goll's tracts which followed a "dying back" ascendant and descendant distribution, respectively. In 2 cases, both of which had intellectual impairment, demyelination of the subcortical and parathalamic areas was observed without U fiber involvement. Abnormal vessels with gross thickening of the adventitia, many of them with lymphocytic cuffs, were seen everywhere, especially in the spinal cord, brain stem, midbrain and meninges, but no relation between these findings and the parenchymal lesions was observed. Also, in the cases with posterior column involvement, neuronal changes and proliferation of satellite cells in the dorsal ganglia were found. All cases showed histological sialoadenitis and none had inflammatory muscle changes. We conclude that the lesions affected the neuraxis in a systemic axial fashion as in degenerative diseases, and did not seem to be secondary to vascular or inflammatory abnormalities.

Entities:  

Mesh:

Year:  1997        PMID: 9100671     DOI: 10.1097/00005072-199704000-00009

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  17 in total

1.  Inflammation in neuroviral diseases.

Authors:  Pascale Giraudon; Arlette Bernard
Journal:  J Neural Transm (Vienna)       Date:  2010-08       Impact factor: 3.575

2.  Spontaneous cell proliferation is associated with poor sensitivity to glucocorticoids in patients infected with HTLV.

Authors:  R P Lopes; M Menna-Barreto; M E Bauer
Journal:  Cell Prolif       Date:  2007-02       Impact factor: 6.831

3.  Inhibition of cyclin-dependent kinase 5 but not of glycogen synthase kinase 3-β prevents neurite retraction and tau hyperphosphorylation caused by secretable products of human T-cell leukemia virus type I-infected lymphocytes.

Authors:  Horacio Maldonado; Eugenio Ramírez; Elias Utreras; María E Pando; Ana M Kettlun; Mario Chiong; Ashok B Kulkarni; Lucía Collados; Javier Puente; Luis Cartier; María A Valenzuela
Journal:  J Neurosci Res       Date:  2011-06-10       Impact factor: 4.164

4.  Update on Neurological Manifestations of HTLV-1 Infection.

Authors:  Abelardo Q-C Araujo
Journal:  Curr Infect Dis Rep       Date:  2015-02       Impact factor: 3.725

5.  Leptomeningeal gadolinium enhancement across the spectrum of chronic neuroinflammatory diseases.

Authors:  Martina Absinta; Irene C M Cortese; Luisa Vuolo; Govind Nair; Manori P de Alwis; Joan Ohayon; Alessandro Meani; Vittorio Martinelli; Roberta Scotti; Andrea Falini; Bryan R Smith; Avindra Nath; Steven Jacobson; Massimo Filippi; Daniel S Reich
Journal:  Neurology       Date:  2017-03-10       Impact factor: 9.910

6.  Conventional magnetic resonance imaging features in patients with tropical spastic paraparesis.

Authors:  Francesca Bagnato; John A Butman; Carlos A Mora; Shiva Gupta; Yoshima Yamano; Talin A Tasciyan; Jeffrey M Solomon; Waldyr J Santos; Roger D Stone; Henry F McFarland; Steven Jacobson
Journal:  J Neurovirol       Date:  2005-12       Impact factor: 2.643

Review 7.  Pathogenesis and treatment of HTLV-I associated myelopathy.

Authors:  G P Taylor
Journal:  Sex Transm Infect       Date:  1998-10       Impact factor: 3.519

8.  Tax posttranslational modifications and interaction with calreticulin in MT-2 cells and human peripheral blood mononuclear cells of human T cell lymphotropic virus type-I-associated myelopathy/tropical spastic paraparesis patients.

Authors:  Fernando Medina; Sebastian Quintremil; Carolina Alberti; Andres Barriga; Luis Cartier; Javier Puente; Eugenio Ramírez; Arturo Ferreira; Yuetsu Tanaka; Maria Antonieta Valenzuela
Journal:  AIDS Res Hum Retroviruses       Date:  2014-01-24       Impact factor: 2.205

9.  Human T-Lymphotropic Virus Type 1-Induced Overexpression of Activated Leukocyte Cell Adhesion Molecule (ALCAM) Facilitates Trafficking of Infected Lymphocytes through the Blood-Brain Barrier.

Authors:  Céline Curis; Florent Percher; Patricia Jeannin; Thomas Montange; Sébastien A Chevalier; Danielle Seilhean; Luis Cartier; Pierre-Olivier Couraud; Olivier Gout; Antoine Gessain; Pierre-Emmanuel Ceccaldi; Philippe V Afonso
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

Review 10.  Treatment of HTLV-I-associated myelopathy/tropical spastic paraparesis: toward rational targeted therapy.

Authors:  Unsong Oh; Steven Jacobson
Journal:  Neurol Clin       Date:  2008-08       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.